Proton Therapy System for Cancer Identification Approved

The Food and Drug Administration has approved a new scanning technology developed by Hitachi for use with the company’s PROBEAT Proton Beam Therapy System. News of the approval was printed by

The spot scanning technology system integrated with the Probeat uses a narrow beam. This system allows for perfected positioning during tumor treatment. Delivery of treatment to the most localized location possible reduces the likelihood that surrounding tissue will receive therapy and be damaged.

The treatment system, the Probeat Proton Beam Therapy System, was originally approved by the FDA in March of 2006. Proton Therapy is different than radiation therapy. This approach allows treating patients with a higher dose of radiation while simultaneously minimizing damage to surrounding healthy tissues.

January 3, 2008 Related topics: Radiation Oncology, Product Approval & Certification, New Technology & Innovation

Today on
Hospital Buyer

HospitalBuyer Undergoing Surgery

HospitalBuyer is on long-term hiatus. We may come back in new and improved form in the future, but...

CT Scans Alter ER Decision-Making About Appendicitis

Data collected from CT scanning of the abdomen and pelvis can alter decision-making by clinicians regarding those patients...

MediNotes Purchase Completed by Eclipsys

Eclipsys Corporation announced that the acquisition (pdf) of MediNotes was finalized. MediNotes is now a wholly owned subsidiary...